Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from WIN-Partners Co., Ltd. ( (JP:3183) ).
WIN-Partners Co., Ltd. reported consolidated net sales of ¥66.28 billion for the nine months ended December 31, 2025, up 9.7% year on year, with operating profit rising 8.0% to ¥2.23 billion and profit attributable to owners of parent increasing 8.4% to ¥1.53 billion, signaling continued earnings expansion despite a slight decline in the equity ratio. The company maintained its full-year forecast, targeting ¥83.5 billion in net sales and ¥3.0 billion in operating profit, and revised its dividend plan upward to a projected annual ¥54 per share for the year ending March 31, 2026, underscoring a commitment to shareholder returns amid steady but moderating growth.
The most recent analyst rating on (JP:3183) stock is a Buy with a Yen1598.00 price target. To see the full list of analyst forecasts on WIN-Partners Co., Ltd. stock, see the JP:3183 Stock Forecast page.
More about WIN-Partners Co., Ltd.
WIN-Partners Co., Ltd., listed on the Tokyo Stock Exchange, operates in the medical-related distribution and services sector, supplying hospitals and healthcare providers with specialized products and solutions. The company focuses on stable, recurring demand in Japan’s healthcare market, leveraging consolidated operations to drive earnings growth and shareholder returns.
Average Trading Volume: 14,733
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen38.87B
For a thorough assessment of 3183 stock, go to TipRanks’ Stock Analysis page.